Menu Philippe 4

What Happened Philippe Menu, Chief Medical Officer of SOPHiA GENETICS (SOPH), sold 5,000 common shares on 2026-05-12. The reported weighted-average sale price was $4.67 per share, for aggregate proceeds of $23,345. This was a sale (not a purchase), and such disposals are often routine.

Key Details

• Transaction date: 2026-05-12; Form 4 filed: 2026-05-13 (timely filing).
• Sale details: 5,000 shares sold; weighted-average price $4.67; price per share ranged $4.56–$4.85 across multiple trades.
• Proceeds: approximately $23,345.
• Shares owned after transaction: not specified in the provided filing details.
• Notable footnotes:
  • F1: Sale made pursuant to a pre-established Rule 10b5-1 trading plan.
  • F2: The $4.67 is a weighted average; the filer can provide breakdown of shares sold at each price on request.

Context A sale executed under a 10b5-1 plan generally indicates the trades were pre-planned and not necessarily a reaction to current company news. The transaction value here is modest (~$23k) and should be viewed as a routine insider sale unless additional filings or disclosures suggest otherwise.